Meeting
2018 Cancer Survivorship Symposium
A brief intervention for chemobrain: Results from a pilot study.
Authors
Jennifer Bennett
University of New Mexico, Albuquerque, NM
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment
Track
Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy
Sub Track
Quality-of-Life Issues
Citation
J Clin Oncol 36, 2018 (suppl 7S; abstr 171)
DOI
10.1200/JCO.2018.36.7_suppl.171
Abstract #
171
Poster Bd #
D9
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.
First Author: Tyler J. Nelson
Poster
2020 ASCO Virtual Scientific Program
CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.
First Author: Jia Liu
Poster
2016 Cancer Survivorship Symposium
Patient-reported outcomes (PROs), unmet need, and psychosocial adaptation among recent breast cancer (BC) survivors.
First Author: Steven C Palmer